| Autor: |
Maglich JM; Nuclear Receptor Discovery Research, GlaxoSmithKline, Research Triangle Park, North Carolina 27709, USA., Sluder AE, Willson TM, Moore JT |
| Jazyk: |
angličtina |
| Zdroj: |
American journal of pharmacogenomics : genomics-related research in drug development and clinical practice [Am J Pharmacogenomics] 2003; Vol. 3 (5), pp. 345-53. |
| DOI: |
10.2165/00129785-200303050-00005 |
| Abstrakt: |
The nuclear receptor (NR) superfamily is a large group of related, pharmacologically important receptors, comprising the targets for over 10% of commonly prescribed drugs. Cross-genome analysis of NR sequence, structure, and biological function, provides an important source of information on the function of human NRs and thus plays a role in NR drug discovery. For example, research on the pregnane X receptor (PXR; NR1I2), constitutive androstane receptor (CAR; NR1I3), hepatocyte nuclear factor 4 (HNF4; NR2A1), and farnesoid X receptor (FXR) illustrate how the study of nonhuman orthologs has provided new insights into NR biology and has increased our understanding of human NRs and orphan NR function. Understanding differences between humans and pharmacological model species may provide useful tools for the development of new NR-binding drugs. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink